Layoffs at Novartis

Pharmaceutical company Novartis is laying off 2,000 workers in Switzerland and the US while adding jobs in China and India, Blooomberg reports. The bulk of the eliminations — 1,100 jobs — will be made in Switzerland with the the rest in the US, affecting a number of departments including R&D, data management, and trial monitoring. Meanwhile, 700 jobs will be created in China and India in data management and trial monitoring.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.